# The Health Service Medicines (Control of Pricesof Branded Medicines) Regulations 2000, Regulation 2: Interpretation


(1) In these Regulations—
“branded health service medicine” means a health service medicine which—
(a) is identifiable by and traded under a specific name given to it by the manufacturer, supplier or holder of a marketing authorisation relating to it; and
(b) is a medicinal product in respect of which a marketing authorisation has been granted;
“initial price” in relation to a presentation of a medicine means—
(a) the price of that presentation which was published on the internet at www.doh.gov.uk/pprsjuly.htm on 20th January 2000 by the Department of Health, or
(b) if no price has been so published but the price is so published of another presentation which is only distinguished by—
(i) type of packaging, that published price; or
(ii) pack size, the price calculated in direct proportion to that published price;
“maximum price” means the price under regulation 3 or, as the case may be, 4;
“marketing authorisation” means a marketing authorisation for a medicinal product for human use granted—
(a) by the competent authorities of the United Kingdom in accordance with Council Directive 65/65/EEC of 26th January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products; or
(b) by the European Agency for the Evaluation of Medicinal Products in accordance with Council Regulation (EEC) No. 2309/93 of 22nd July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products;
“presentation” means a particular form of a medicine which may be distinguished from other forms of that medicine by reference to its active ingredients and excipients, pack size, type of packaging, clinical indications or indicated method of administration for use in clinical practice;
“supply” means supply by way of sale.
(2) A health service medicine is supplied on the date on which a contract for its sale is concluded.
(3) Any reference in these Regulations to a numbered regulation is a reference to a regulation which bears that number in these Regulations and any reference to a numbered paragraph in a regulation is a reference to the paragraph in that regulation which bears that number, unless the context otherwise requires.

---
Source: https://www.legislation.gov.uk/uksi/2000/123/regulation/2 (the official version)
Page: https://openlegislation.uk/health-service-medicines-control-of-pricesof-branded-medicines-regulations-2000/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

